{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:09:38Z","timestamp":1787501378768,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast angiosarcomas (AS) are rare and aggressive malignancies, categorised as primary angiosarcoma (PAS) and radiation-associated angiosarcoma (RAAS). Due to its rarity, large series of PAS and RAAS are limited. We aimed to analyse the outcome of a large cohort of angiosarcomas with emphasis on the prognostic factors, latency, margin width and significance of locoregional recurrences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was conducted on angiosarcomas managed at a large UK Regional Sarcoma Centre between 2013 and 2024. Clinical, pathological, disease-free survival (DFS) and overall survival (OS) data were collected. The interval between radiotherapy delivery and the development of angiosarcoma was calculated. Cox regression models and binary logistic regression were utilised for optimal threshold values for resection margins and patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PAS presented at a younger age (median 31 vs 71\u00a0years for RAAS). A significant shortening of latency between radiotherapy and onset of RAAS was found (r\u2009=\u2009\u2212\u20090.719,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). DFS and OS were 59.6%, and 54.2% respectively. Smaller microscopic resection margins were significantly associated with recurrence (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Recurrence was a strong predictor of mortality, HR\u2009=\u20092.856, p\u2009=\u20090.005. Mean survival with and without angiosarcoma recurrences was 32.9 and 80.5\u00a0months respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). Resection margins\u2009\u2265\u200910\u00a0mm were significantly associated with lower rates of recurrences (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044, OR\u2009=\u20090.323). However, resection margin distance did not directly impact survival (HR\u2009=\u20091.002,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090. 798). Cox regression analysis showed angiosarcoma size was not a predictor of survival (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.278, HR\u2009=\u20091.002). Neither patient age nor the angiosarcoma histological grade correlated with recurrences or patient survival. C-Myc immunohistochemistry was positive in four of nine (44.44%) PASs and in 95.52% of RAAS. Its expression did not correlate with patient survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Over the last decade, the number of diagnosed RAAS cases has increased with a shortening in the interval between radiotherapy and onset of RAAS. Margin status and recurrences, but not angiosarcoma grade or size, impact survival. Achieving a clear surgical margin is therefore critical for improved patients\u2019 outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02265-0","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:22:43Z","timestamp":1774714963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic significance of clinicopathological parameters, margin width and locoregional recurrences on outcome of primary and radiation associated breast angiosarcoma- results from a large UK sarcoma regional service"],"prefix":"10.1186","volume":"28","author":[{"given":"Samar","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salena","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Hallissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"El-Ghobashy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"2265_CR1","unstructured":"Spiker AM, Mangla A, Ramsey ML: Angiosarcoma. In: StatPearls. edn. Treasure Island (FL); 2025."},{"issue":"10","key":"2265_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","volume":"11","author":"RJ Young","year":"2010","unstructured":"Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11(10):983\u201391.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2265_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.5858\/arpa.2014-0581-RS","volume":"140","author":"S Shah","year":"2016","unstructured":"Shah S, Rosa M. Radiation-associated angiosarcoma of the breast: clinical and pathologic features. Arch Pathol Lab Med. 2016;140(5):477\u201381.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2265_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-019-05432-4","volume":"178","author":"Y Abdou","year":"2019","unstructured":"Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M. Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat. 2019;178(3):523\u201333.","journal-title":"Breast Cancer Res Treat"},{"key":"2265_CR5","volume":"2011","author":"C Desbiens","year":"2011","unstructured":"Desbiens C, Hogue JC, Levesque Y. Primary breast angiosarcoma: avoiding a common trap. Case Rep Oncol Med. 2011;2011:517047.","journal-title":"Case Rep Oncol Med"},{"issue":"1","key":"2265_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40792-020-00841-w","volume":"6","author":"E Shiraki","year":"2020","unstructured":"Shiraki E, Kang Y, Shibayama T, Tsuyuki S. Two cases of breast angiosarcoma after breast conserving surgery. Surg Case Rep. 2020;6(1):81.","journal-title":"Surg Case Rep"},{"issue":"Suppl 5","key":"2265_CR7","doi-asserted-by":"publisher","first-page":"S510","DOI":"10.21037\/tcr.2019.07.38","volume":"8","author":"E Esposito","year":"2019","unstructured":"Esposito E, Avino F, di Giacomo R, Donzelli I, Marone U, Melucci MT, et al. Angiosarcoma of the breast, the unknown-a review of the current literature. Transl Cancer Res. 2019;8(Suppl 5):S510\u20137.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"2265_CR8","first-page":"3","volume":"36","author":"I Machado","year":"2021","unstructured":"Machado I, Giner F, Lavernia J, Cruz J, Traves V, Requena C, et al. Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis. Histol Histopathol. 2021;36(1):3\u201318.","journal-title":"Histol Histopathol"},{"issue":"6","key":"2265_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4132\/jptm.2022.08.31","volume":"56","author":"E Abada","year":"2022","unstructured":"Abada E, Jang H, Kim S, Ali-Fehmi R, Bandyopadhyay S. A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma. J Pathol Transl Med. 2022;56(6):342\u201353.","journal-title":"J Pathol Transl Med"},{"key":"2265_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-016-0060-4","volume":"6","author":"A Dangoor","year":"2016","unstructured":"Dangoor A, Seddon B, Gerrand C, Grimer R, Whelan J, Judson I. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016;6:20.","journal-title":"Clin Sarcoma Res"},{"issue":"1","key":"2265_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41416-024-02674-y","volume":"132","author":"AJ Hayes","year":"2025","unstructured":"Hayes AJ, Nixon IF, Strauss DC, Seddon BM, Desai A, Benson C, et al. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2025;132(1):11\u201331.","journal-title":"Br J Cancer"},{"issue":"4","key":"2265_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/bjs.10696","volume":"105","author":"L Feinberg","year":"2018","unstructured":"Feinberg L, Srinivasan A, Singh JK, Parry M, Stevenson J, Jeys L, et al. Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. Br J Surg. 2018;105(4):401\u20139.","journal-title":"Br J Surg"},{"issue":"2","key":"2265_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0344-0338(11)80700-4","volume":"190","author":"P Hermanek","year":"1994","unstructured":"Hermanek P, Wittekind C. The pathologist and the residual tumor (R) classification. Pathol Res Pract. 1994;190(2):115\u201323.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2265_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jso.27772","volume":"130","author":"LV Selby","year":"2024","unstructured":"Selby LV, Clark E, Chen JL, Tinoco G, Beane JD, Pollock RE, et al. Use of neoadjuvant paclitaxel in breast angiosarcoma-impact on surgical resection and response rates. J Surg Oncol. 2024;130(3):579\u201385.","journal-title":"J Surg Oncol"},{"issue":"5","key":"2265_CR15","first-page":"577","volume":"159","author":"F Gianessi","year":"2024","unstructured":"Gianessi F, Toni G, Pacetti L, Gaban A, Odorici G, Borghi A. Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder. Ital J Dermatol Venerol. 2024;159(5):577\u20139.","journal-title":"Ital J Dermatol Venerol"},{"issue":"4","key":"2265_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/bjs\/znaa128","volume":"108","author":"J Banks","year":"2021","unstructured":"Banks J, George J, Potter S, Gardiner MD, Ives C, Shaaban AM, et al. Breast Angiosarcoma Surveillance Study: UK national audit of management and outcomes of angiosarcoma of the breast and chest wall. Br J Surg. 2021;108(4):388\u201394.","journal-title":"Br J Surg"},{"issue":"5","key":"2265_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COC.0000000000000077","volume":"39","author":"ER Ghareeb","year":"2014","unstructured":"Ghareeb ER, Bhargava R, Vargo JA, Florea AV, Beriwal S. Primary and radiation-induced breast angiosarcoma: clinicopathologic predictors of outcomes and the impact of adjuvant radiation therapy. Am J Clin Oncol. 2014;39(5):463\u20137.","journal-title":"Am J Clin Oncol"},{"key":"2265_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14080859","author":"S Cozzi","year":"2024","unstructured":"Cozzi S, Finocchi Ghersi S, Tava F, Bardoscia L, Najafi M, Ruggieri MP, et al. Radiation-associated angiosarcoma of the breast: the state of the art of a rare and aggressive disease. J Pers Med. 2024. https:\/\/doi.org\/10.3390\/jpm14080859.","journal-title":"J Pers Med"},{"key":"2265_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101726","volume":"41","author":"J Mergancova","year":"2022","unstructured":"Mergancova J, Lierova A, Coufal O, Zatecky J, Melichar B, Zednikova I, et al. Radiation-associated angiosarcoma of the breast: an international multicenter analysis. Surg Oncol. 2022;41:101726.","journal-title":"Surg Oncol"},{"key":"2265_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-017-0081-7","volume":"7","author":"RB Cohen-Hallaleh","year":"2017","unstructured":"Cohen-Hallaleh RB, Smith HG, Smith RC, Stamp GF, Al-Muderis O, Thway K, et al. Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series. Clin Sarcoma Res. 2017;7:15.","journal-title":"Clin Sarcoma Res"},{"issue":"2","key":"2265_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamaoncol.2018.6643","volume":"5","author":"AJM Rombouts","year":"2019","unstructured":"Rombouts AJM, Huising J, Hugen N, Siesling S, Poortmans PM, Nagtegaal ID, et al. Assessment of radiotherapy-associated angiosarcoma after breast cancer treatment in a Dutch population-based study. JAMA Oncol. 2019;5(2):267\u20139.","journal-title":"JAMA Oncol"},{"issue":"2","key":"2265_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12282-023-01535-5","volume":"31","author":"HH Wong","year":"2024","unstructured":"Wong HH, Cojocaru E, Watkins J, James S, Aloysius T, Harrington J, et al. Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre. Breast Cancer. 2024;31(2):272\u201382.","journal-title":"Breast Cancer"},{"issue":"4","key":"2265_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl482","volume":"18","author":"M Moe","year":"2007","unstructured":"Moe M, Bertelli G. Breast angiosarcoma following lumpectomy and radiotherapy for breast cancer: a case with short latent period and false negative result on biopsies. Ann Oncol. 2007;18(4):801.","journal-title":"Ann Oncol"},{"issue":"3","key":"2265_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.14316\/pmp.2020.31.3.124","volume":"31","author":"HD Huh","year":"2020","unstructured":"Huh HD, Kim S. History of radiation therapy technology. Prog Med Phys. 2020;31(3):124\u201334.","journal-title":"Prog Med Phys"},{"issue":"1","key":"2265_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jphys.2018.11.001","volume":"65","author":"MJ Hancock","year":"2019","unstructured":"Hancock MJ. Appraisal of clinical practice guideline: early and locally advanced breast cancer: diagnosis and management. NICE guideline [NG101]. J Physiother. 2019;65(1):57.","journal-title":"J Physiother"},{"issue":"25","key":"2265_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/WWBF1044","volume":"27","author":"AM Brunt","year":"2023","unstructured":"Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Bloomfield DJ, Chan C, et al. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. Health Technol Assess. 2023;27(25):1\u2013176.","journal-title":"Health Technol Assess"},{"key":"2265_CR27","first-page":"1917","volume":"45","author":"CA Kotwall","year":"1999","unstructured":"Kotwall CA. Breast cancer treatment and chemoprevention. Can Fam Physician. 1999;45:1917\u201324.","journal-title":"Can Fam Physician"},{"key":"2265_CR28","unstructured":"The Royal College of Radiologists: Guidelines on radiation therapy for breast cancer during the COVID-19 pandemic 2020. Available at https:\/\/www.rcr.ac.uk\/publication\/postoperative-radiotherapy-breast-cancer-uk-consensus-statements. 2020."},{"issue":"12","key":"2265_CR29","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s11864-024-01253-w","volume":"25","author":"S Rhodes","year":"2024","unstructured":"Rhodes S, Miller DG, Chino F. \u201cWhen less is more\u201d: paradigm shifts in radiation treatment for early-stage breast cancer. Curr Treat Options Oncol. 2024;25(12):1495\u2013505.","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"2265_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1245\/s10434-019-08132-x","volume":"27","author":"SH Salminen","year":"2020","unstructured":"Salminen SH, Blomqvist CP. ASO author reflections: registry-based analysis of radiation-associated angiosarcoma of the breast provides unbiased insights into this disease. Ann Surg Oncol. 2020;27(4):1011\u20132.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2265_CR31","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/COC.0000000000000753","volume":"43","author":"PM Gutkin","year":"2020","unstructured":"Gutkin PM, Ganjoo KN, Lohman M, von Eyben R, Charville GW, Nazerali RS, et al. Angiosarcoma of the breast: management and outcomes. Am J Clin Oncol. 2020;43(11):820\u20135.","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"2265_CR32","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1111\/ans.19231","volume":"94","author":"E Mor","year":"2024","unstructured":"Mor E, Baker B, Henderson MA, Lazarakis S, Mitchell C, Speakman D, et al. Outcomes following extended resection of radiation-induced angiosarcoma of the breast: a sarcoma unit experience and systematic review. Anz J Surg. 2024;94(12):2150\u20138.","journal-title":"Anz J Surg"},{"key":"2265_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.breast.2019.09.006","volume":"48","author":"M Taffurelli","year":"2019","unstructured":"Taffurelli M, Pellegrini A, Meattini I, Orzalesi L, Tinterri C, Roncella M, et al. Corrigendum to \u201csecondary breast angiosarcoma: a multicentre retrospective survey by the national Italian association of breast surgeons (ANISC)\u201d [Breast 2019 56-60]. Breast. 2019;48:101.","journal-title":"Breast"},{"issue":"10","key":"2265_CR34","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.ejca.2014.03.002","volume":"50","author":"AL Depla","year":"2014","unstructured":"Depla AL, Scharloo-Karels CH, de Jong MA, Oldenborg S, Kolff MW, Oei SB, et al. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J Cancer. 2014;50(10):1779\u201388.","journal-title":"Eur J Cancer"},{"key":"2265_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251317842","volume":"17","author":"JT Thiel","year":"2025","unstructured":"Thiel JT, Bauer M, Daigeler A, Kavaka V, Kolbenschlag J, Steiner D, et al. Radiation-associated angiosarcoma of the breast: radical resection technique of the entire radiation field. Ther Adv Med Oncol. 2025;17:17588359251317842.","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"2265_CR36","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.bjps.2011.02.014","volume":"64","author":"A Lindford","year":"2011","unstructured":"Lindford A, Bohling T, Vaalavirta L, Tenhunen M, Jahkola T, Tukiainen E. Surgical management of radiation-associated cutaneous breast angiosarcoma. J Plast Reconstr Aesthet Surg. 2011;64(8):1036\u201342.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"7","key":"2265_CR37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3109\/0284186X.2014.983657","volume":"54","author":"E Styring","year":"2015","unstructured":"Styring E, Klasson S, Rydholm A, Vult von Steyern F. Radiation-associated angiosarcoma after breast cancer: improved survival by excision of all irradiated skin and soft tissue of the thoracic wall? A report of six patients. Acta Oncol. 2015;54(7):1078\u201380.","journal-title":"Acta Oncol"},{"issue":"1","key":"2265_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1245\/s10434-021-10477-1","volume":"29","author":"S Guram","year":"2022","unstructured":"Guram S, Covelli AM, O\u2019Neill AC, Shultz DB, Demicco EG, Gupta AA, et al. Multidisciplinary intervention in radiation-associated angiosarcoma of the breast: patterns of recurrence and response to treatment. Ann Surg Oncol. 2022;29(1):522\u201332.","journal-title":"Ann Surg Oncol"},{"key":"2265_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103825","volume":"78","author":"SJC van der Burg","year":"2024","unstructured":"van der Burg SJC, Reijers SJM, Kuijpers A, Heimans L, Scholten AN, Haas RLM, et al. Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: a retrospective single center study. Breast. 2024;78:103825.","journal-title":"Breast"},{"issue":"5","key":"2265_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23240","volume":"63","author":"HY Chang","year":"2024","unstructured":"Chang HY, Dermawan JK, Kuba MG, Crago AM, Singer S, Tap W, et al. Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced pathologic response in breast angiosarcoma. Genes Chromosomes Cancer. 2024;63(5):e23240.","journal-title":"Genes Chromosomes Cancer"},{"issue":"19","key":"2265_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193163","volume":"17","author":"Y Fujisawa","year":"2025","unstructured":"Fujisawa Y. Novel therapeutic approaches for cutaneous angiosarcoma, particularly focusing on immune checkpoint inhibitors. Cancers Basel. 2025;17(19):3163.","journal-title":"Cancers Basel"},{"issue":"32","key":"2265_CR42","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","volume":"26","author":"N Penel","year":"2008","unstructured":"Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008;26(32):5269\u201374.","journal-title":"J Clin Oncol"},{"key":"2265_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082251","author":"KM Heinhuis","year":"2020","unstructured":"Heinhuis KM, Ns IJ, van der Graaf WTA, Kerst JM, Schrage Y, Beijnen JH, et al. Neoadjuvant systemic treatment of primary angiosarcoma. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12082251.","journal-title":"Cancers (Basel)"},{"key":"2265_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000787","author":"A Constantinidou","year":"2020","unstructured":"Constantinidou A, Sauve N, Stacchiotti S, Blay J-Y, Vincenzi B, Grignani G, et al. Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study. ESMO Open. 2020. https:\/\/doi.org\/10.1136\/esmoopen-2020-000787.","journal-title":"ESMO Open"},{"issue":"15","key":"2265_CR45","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-23-0443","volume":"29","author":"AC Degnim","year":"2023","unstructured":"Degnim AC, Siontis BL, Ahmed SK, Hoskin TL, Hieken TJ, Jakub JW, et al. Trimodality therapy improves disease control in radiation-associated angiosarcoma of the breast. Clin Cancer Res. 2023;29(15):2885\u201393.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2265_CR46","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1245\/s10434-019-08085-1","volume":"27","author":"SH Salminen","year":"2020","unstructured":"Salminen SH, Wiklund T, Sampo MM, Tarkkanen M, Pulliainen L, Bohling TO, et al. Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population. Ann Surg Oncol. 2020;27(4):1002\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2265_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3292-7","volume":"17","author":"M Yin","year":"2017","unstructured":"Yin M, Wang W, Drabick JJ, Harold HA. Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study. BMC Cancer. 2017;17(1):295.","journal-title":"BMC Cancer"},{"issue":"2","key":"2265_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1066896920930100","volume":"29","author":"C Webb","year":"2021","unstructured":"Webb C, Partain N, Koduru P, Hwang H, Sarode VR. Secondary angiosarcoma with C-MYC amplification following prophylactic bilateral mastectomy and autologous breast reconstruction: report of a case and review of the literature. Int J Surg Pathol. 2021;29(2):205\u201310.","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"2265_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10549-015-3379-2","volume":"151","author":"C Fraga-Guedes","year":"2015","unstructured":"Fraga-Guedes C, Andre S, Mastropasqua MG, Botteri E, Toesca A, Rocha RM, et al. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression. Breast Cancer Res Treat. 2015;151(1):131\u201340.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2265_CR50","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/his.14433","volume":"79","author":"MG Kuba","year":"2021","unstructured":"Kuba MG, Xu B, D\u2019Angelo SP, Rosenbaum E, Plitas G, Ross DS, et al. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast. Histopathology. 2021;79(5):836\u201346.","journal-title":"Histopathology"},{"key":"2265_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2022.152096","volume":"63","author":"AG Hogeboom-Gimeno","year":"2023","unstructured":"Hogeboom-Gimeno AG, van Ravensteijn SG, Desar IME, Hillebrandt-Roeffen MHS, van Cleef PHJ, Bonenkamp JJ, et al. MYC amplification in angiosarcoma depends on etiological\/clinical subgroups \u2013 diagnostic and prognostic value. Ann Diagn Pathol. 2023;63:152096.","journal-title":"Ann Diagn Pathol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02265-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02265-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02265-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:05:08Z","timestamp":1781643908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02265-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2265"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02265-0","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as a registered audit at the Queen Elizabeth Hospital Birmingham (Clinical Audit Registration & Management System). Formal ethical approval and individual patient consent were not required in accordance with audit regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}